尼卡的平与开搏通治疗老年高血压的价效关系

EFFECTIVE ASSESSMENT ON NICADIPINE ANDCAPOTEN IN TREATMENT OF AGED HYPER-TENSIVES

１００例老年高血压患者随机分为两组，尼卡的平组（３０～６０ｍｇ／日）５０例，开搏通组（２５～５０ｍｇ／日）５０例，疗程４周。结果示二者在改善老年高血压的生活质量及降压疗效相似，但尼卡的平价格更便宜，有更好的价效关系。

lthough the precise cause of hypertension is notknown,empire treatment indicated to reduce cardio-cere-brovascular risk.Several pharmacologic classes of anti-hyper-tensive drugs are available to reduce the blood pressure, butthey may have different cost effectiveness,The therapeutic goal in aged hypertension is not only to normalize blood pres- sure but also to improve quality of life and get good cost effec- tiveness。In this study we compared the cost-utility of Nicadip- ine therapy (30～60mg/day),a calcium antagonist,with capoten(25 ～ 50mg/day )。There were 50 patients in each group who were randonized.The results showed that Nicadip- ine therapy was more effective in the anti-hypertensive action than Capoten and in improvement of quality of life was similar to it.Nicadipine which was made in China one was cheaper than Capoten。Thus,it had better cost-utility relation。It was concluded that both Nicadipine and Capoten were able to im- prove quality of life but they cause different cost-utility rela- tion in aged hypertensive。